Riskpilot← Back to searchSign inGet full accessPentas Läkartjänster AB
ABActiveOrg 5592022536Apelvägen 12Medical specialists activities · NACE 8622Est. 20190 employees
Revenue 2025
SEK 1,9M
+26% vs 2024
EBITDA margin
94.0%
+27% vs 2024
Equity ratio
88.5%
Financial strength
Net profit 2025
SEK 1,6M
+51% vs 2024
| Revenue | SEK 1,9M | +26% |
| EBITDA | SEK 1,8M | +27% |
| Net profit | SEK 1,6M | +51% |
| Total assets | SEK 5,4M | +30% |
| Equity | SEK 4,8M | +43% |
| Employees | 0 | — |
Legal name
Pentas Läkartjänster AB
Org number
5592022536
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva läkartjänster samt medicinsk hälso- och sjukvård inom ögon och därmed förenlig verksamhet. Vidare handel med värdepapper och fastigheter och därmed förenlig verksamhet.
Address
Apelvägen 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 243 | 903 | 927 | 1 492 | 1 886 |
| Staff expenses | — | — | −6 | −0 | −8 |
| EBITDA | 1 164 | 835 | 836 | 1 396 | 1 773 |
| Depreciation & amort. | −0 | — | −35 | −36 | −45 |
| EBIT | 1 164 | 835 | 801 | 1 360 | 1 728 |
| Net financials | — | −2 | −2 | 3 | 38 |
| Profit before tax | 1 164 | 633 | 598 | 1 363 | 2 066 |
| Tax | −249 | −131 | −124 | −284 | −432 |
| Net profit | 915 | 501 | 475 | 1 079 | 1 634 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 475 | 2 936 | 3 331 | 4 167 | 5 428 |
| Equity | 1 494 | 1 815 | 2 290 | 3 369 | 4 802 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 681 | 621 | 341 | 98 | 225 |
| Total debt | 681 | 621 | 341 | 98 | 225 |
EBITDA margin
94.0%
This company
15.8%
Market median
+495% vs market
20212025
Equity ratio
88.5%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
34.0%
This company
18.4%
Market median
+85% vs market
20212025
Net profit margin
86.6%
This company
8.1%
Market median
+969% vs market
20212025
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pentas Läkartjänster AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eleni Evangelidou | Deputy Board Member | 0 companies |
| Achillefs Filios | Board of Directors | 0 companies |